CAMBRIDGE, Mass., July 3, 2026 /PRNewswire/ -- Nona Biosciences ('Nona' or the 'Company'), a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, ...
Vietnam Investment Review on MSN
Nona Biosciences Lonza develop blood brain barrier crossing antibody platform for CNS
CAMBRIDGE, Mass., July 2, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today ...
Nona's cutting-edge technology platform enables a fully integrated antibody discovery from protein design and single cell-based antibody screening to next-generation sequencing, antibody modeling and ...
Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative ...
Nona Biosciences' proprietary Harbour Mice ® platform employs transgenic mice to generate fully human monoclonal antibodies in both the conventional two heavy and two light chain (H2L2) format and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results